Cargando…

SAT-281 Relationship between Socioeconomic Status, Adherence and Outcomes to Growth Hormone Treatment in Children: Real-World Treatment Patterns in Israel

Background: The goals of growth hormone treatment (GHT) during childhood and adolescence are to normalize height velocity and attain a final adult height within the normal range. Despite decades of use, little data is available on GHT patterns and outcomes in a real-life environment. Maccabi Health...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ben-Ari, Tal, Gabriel, Chodick, Shalev, Varda, Goldstein, Dalit, Gomez, Roy, Landau, Zohar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Pediatric Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551812/ http://dx.doi.org/10.1210/js.2019-SAT-281

Ejemplares similares

Real-World Treatment Patterns and Outcomes of Growth Hormone Treatment Among Children in Israel Over the Past Decade (2004–2015)
por: Ben-Ari, Tal, et al.
Publicado: (2021)

SAT-106 Growth Hormone Treatment Response in Children
por: Rath, Mitchell, et al.
Publicado: (2020)

SAT-303 Combined Treatment of Gonadotropin Releasing Hormone Agonist and Recombinant Human Growth Hormone in Cental Precocious Puberty Patient with Underlying Leri Weill Dyschondrosteosis
por: Choi, Ju-hee, et al.
Publicado: (2019)

Epidemiology of treatment resistant depression among major depressive disorder patients in Israel
por: Sharman Moser, Sarah, et al.
Publicado: (2022)

SAT-090 Factors Affecting IGF-1 Level and Correlation with Growth Response During Growth Hormone Treatment in LGS Patients
por: Kim, Jihyun, et al.
Publicado: (2020)

SAT-108 Growth Hormone Deficiency in a Patient with Ectodermal Dysplasia
por: Alkhaled, Lina, et al.
Publicado: (2020)

SUN-281 Topiramate-Induced BMI Reduction in an Adolescent with Severe Obesity Associated with Classical Congenital Adrenal Hyperplasia
por: Seagroves, Amy, et al.
Publicado: (2019)

SAT-109 Utilizing Pituitary Volume (PV) and the Growth Hormone Stimulation Test (GHST) to Jointly Define the Etiology of Short Stature (SS): An Improved Diagnostic Criteria for Growth Hormone Treatment
por: Patale, Tara Prasanna, et al.
Publicado: (2020)

SAT-284 Sex Hormone Replacement Therapy in Turner Syndrome and the Impact on Morbidity and Mortality
por: Viuff, Mette, et al.
Publicado: (2019)

Use of Healthcare Services Following Severe Hypoglycemia in Patients with Diabetes: Analysis of Real-World Data
por: Goldstein, Dalit, et al.
Publicado: (2016)

SAT-305 Hyperactive Behavioral Change during Combination Treatment of Aromatase Inhibitor and Recombinant Human Growth Hormone in Early Puberty Patient: A Case Report
por: Choi, Ju-hee, et al.
Publicado: (2019)

SAT-102 Height Improvement with Recombinant Human Growth Hormone Therapy at Terminal Stage of Growth
por: Kim, Dae Hyun, et al.
Publicado: (2020)

SAT-088 The Incidence of Neurological Symptoms During Growth Hormone Therapy in Patients with Chiari Malformation
por: Alexandrov, Alice, et al.
Publicado: (2020)

SAT-107 Improved Adult Height in Brazilian Turner Syndrome Patients Treated with Growth Hormone
por: Scalco, Renata Da Cunha, et al.
Publicado: (2020)

SAT-308 Obsessive and Compulsive Behavioral Change during Combination Treatment of Aromatase Inhibitor and Recombinant Human Growth Hormone in Early Puberty Patient: A Case Report
por: Choi, Ju-hee, et al.
Publicado: (2019)

SAT-105 The Natural History of Pituitary Cysts in Patients with Growth Hormone Deficiency and Idiopathic Short Stature
por: El-Naghy, Zeyad, et al.
Publicado: (2020)

SAT-101 The Booster Effect of Aromatase Inhibitor to Overcome Waning Effect of Recombinant Human Growth Hormone
por: Kim, Dae Hyun, et al.
Publicado: (2020)

Sub-Optimal Adherence With Daily Growth Hormones Increases With Each Year of Treatment in a US Commercial Claims Database
por: Loftus, Jane, et al.
Publicado: (2021)

SAT-307 Sudden Unexpected Vaginal Bleeding Caused by Temporal Reactivation of Hypothalamic-Hypophyseal-Gonadal Axis during Gonadotropin Releasing Hormone Agonist Treatment for Central Precocious Puberty
por: Kim, Dae Hyun, et al.
Publicado: (2019)

SAT-304 Unexplained Asymptomatic Hyperestrogenism in Central Precocious Puberty Patient Treated with Gonadotropin Releasing Hormone Agonist
por: Kim, Dae Hyun, et al.
Publicado: (2019)

The effectiveness of insulin glargine 300 U/mL among type 2 diabetes patients: Analysis of a real‐world data in Israel
por: Melzer Cohen, Cheli, et al.
Publicado: (2020)

SAT-291 Gonadotropin Releasing Hormone Agonist Therapy Improves Hyperandrogenism in an Adolescent with Type A Insulin Resistance Syndrome
por: Paprocki, Emily, et al.
Publicado: (2019)

Gynecomastia: A systematic review of pharmacological treatments
por: Berger, Ori, et al.
Publicado: (2022)

SAT-LB16 Maintenance of Favorable Treatment Effect of Once-Weekly TransCon hGH for Children With Growth Hormone Deficiency: Interim Analysis From the Enlighten Long-Term Extension Trial
por: Maniatis, Aristides K, et al.
Publicado: (2020)

SAT-092 Positive Effect of an Early Start of Growth Hormone Therapy on Auxology and Metabolic Parameters in Children with Prader Willi Syndrome
por: Gohlke, Bettina, et al.
Publicado: (2020)

SAT581 Parathyroid Hormone Related Protein-induced Hypercalcemia In Medullary Thyroid Carcinoma In Pediatric Patient With MEN2A
por: Ackah, Sarah Adjepomaa, et al.
Publicado: (2023)

SAT-272 A Phase 2 Comparison of a Stable Liquid Glucagon to Placebo for the Treatment of Congenital Hyperinsulinism
por: Thornton, Paul, et al.
Publicado: (2019)

SAT-245 Estimated Insulin Sensitivity Score Predicts Post-OSTT Insulin Secretion and GI Hormone Differences in Adolescents with Obesity and PCOS
por: Garcia Reyes, Yesenia, et al.
Publicado: (2019)

SAT-LB19 Is There a Need to Use Gadolinium Contrast for Pituitary MRI in the Evaluation of Pediatric Short Stature and Growth Hormone Deficiency?
por: Almaghraby, Abdullah, et al.
Publicado: (2020)

SUN-257 Adherence Rates to Growth Hormone Therapy: ECOS Study Analysis of Australian Data Compared with Global Adherence Rates
por: Reakes, Shannon, et al.
Publicado: (2019)

SAT-LB12 Once-Weekly Somapacitan vs Daily Growth Hormone in Growth Hormone Deficiency: 2-Year Safety Results From Real 3, a Randomized Phase 2 Trial
por: Savendahl, Lars S, et al.
Publicado: (2020)

Growth Hormone Stimulation Testing Patterns Contribute to Gender Disparities in Growth Hormone Treatment
por: Kamoun, Camilia, et al.
Publicado: (2021)

SAT-306 An Atypical Presentation of Klinefelter Syndrome
por: Shah, Avni, et al.
Publicado: (2019)

SAT-258 Anti-Mullerian Hormone (AMH) Levels Reflect Ovarian Follicle Count by MRI but Not Ovarian Size in Young Patients with Polycystic Ovary Syndrome
por: Pereira-Eshraghi, Camila, et al.
Publicado: (2019)

SAT-282 Outcomes in Children Treated with Growth Hormone for Prader-Willi Syndrome: Data from the Answer® Program and Nordinet® International Outcome Study (IOS)
por: Angulo, Moris, et al.
Publicado: (2019)

SAT-LB11 Adult Growth Hormone Deficiency Transition Care From Pediatric to Adult Services: Insights From a US Advisory Board
por: Yuen, Kevin C J, et al.
Publicado: (2020)

Factors Driving Patient Preferences for Growth Hormone Treatment in Japanese Children With Growth Hormone Deficiency
por: Tanaka, Toshiaki, et al.
Publicado: (2021)

SAT-276 Vitamin D Deficiency In Hashimoto's Thyroiditis
por: Arora, Sumeet, et al.
Publicado: (2019)

SAT-252 Risk Behaviors and Metabolic Syndrome in Adolescents
por: Marques, Adriana, et al.
Publicado: (2019)

SAT-289 An Unusual Virilizing Ovarian Tumor in Adolescence
por: Force, Bahar, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s0tuf1g20rqfm0embodadr8gh5